Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other financing activities (2018 - 2024)

Historic Other financing activities for Crinetics Pharmaceuticals (CRNX) over the last 3 years, with Q4 2024 value amounting to -$15.9 million.

  • Crinetics Pharmaceuticals' Other financing activities fell 361771.56% to -$15.9 million in Q4 2024 from the same period last year, while for Mar 2025 it was -$12.1 million, marking a year-over-year decrease of 40936.86%. This contributed to the annual value of $26000.0 for FY2023, which is N/A changed from last year.
  • Crinetics Pharmaceuticals' Other financing activities amounted to -$15.9 million in Q4 2024, which was down 361771.56% from $4.3 million recorded in Q1 2024.
  • Over the past 5 years, Crinetics Pharmaceuticals' Other financing activities peaked at $4.3 million during Q1 2024, and registered a low of -$15.9 million during Q4 2024.